cefixime has been researched along with cefpodoxime in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barbour, A; Derendorf, H; Grant, M; Murthy, B; Sabarinath, SN; Schmidt, S; Seubert, C; Skee, D | 1 |
| Barry, PM; Klausner, JD; Liska, S; Pandori, M; Ren, A; Whittington, WL; Wu, A | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
| Brickner, SJ; Casavant, J; Deschenes, L; Finegan, SM; Flanagan, ME; George, DM; Gootz, TD; Granskog, K; Hardink, JR; Hoang, T; Huband, MD; Lall, M; Lamb, L; Marra, A; Mitton-Fry, M; Mueller, JP; Mullins, LM; Noe, MC; O'Donnell, JP; Pattavina, D; Penzien, JB; Schuff, BP; Sun, J; Whipple, DA; Young, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cefixime and cefpodoxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cefixime and cefpodoxime
| Article | Year |
|---|---|
Soft-tissue penetration of ceftobiprole in healthy volunteers determined by in vivo microdialysis.
Topics: Adipose Tissue; Adult; Anti-Bacterial Agents; Cephalosporins; Humans; Infusions, Intravenous; Male; Microdialysis; Muscle, Skeletal; Young Adult | 2009 |
5 other study(ies) available for cefixime and cefpodoxime
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; California; Cefixime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Molecular Sequence Data; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Homology, Amino Acid | 2009 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols.
Topics: | 2011 |